From pericytes to perivascular tumours: correlation between pathology, stem cell biology, and tissue engineering
Pericytes were once thought only to aid in angiogenesis and blood pressure control. Gradually, the known functions of pericytes and other perivascular stem cells (PSC) have broadly increased. The following review article will summarize the known functions and importance of pericytes across disciplines of pathology, stem cell biology, and tissue engineering.
A literature review was performed for studies examining the importance of pericytes in pathology, stem cell biology, and tissue engineering.
The importance of pericytes most prominently includes the identification of the perivascular identity of mesenchymal stem cells (or MSC). Now, pericytes and other PSC are known to display surface markers and multilineage differentiation potential of MSC. Accordingly, interest in the purification and use of PSC for mesenchymal tissue formation and regeneration has increased. Significant demonstration of in vivo efficacy in bone and muscle regeneration has been made in laboratory animals. Contemporaneously with the uncovering of an MSC identity for pericytes, investigators in tumour biology have found biologically relevant roles for pericytes in tumor formation, lymphovascular invasion, and perivascular tumor spread. As well, the contribution of pericytes to perivascular tumors has been examined (and debated), including glomus tumour, myopericytoma and solitary fibrous tumour/hemangiopericytoma. In addition, an expanding recognition of pericyte mimicry and perivascular tumour invasion has occurred, encompassing common malignancies of the brain and skin.
In summary, pericytes have a wide range of roles in health and disease. Pericytes are being increasingly studied for their role in tumour formation, growth and invasion. Likewise, the application of pericytes/PSC for mesenchymal tissue engineering is an expanding field of interest.
KeywordsPericyte Adventitial cell Glomus tumour Myopericytoma Solitary fibrous tumour hemangiopericytoma
Clinical specimens were recovered and presented with appropriate institutional approval, under University of California, Los Angeles IRB # 13–000918. The authors thank the staff of Translational Pathology Core Laboratory, and AS James for their excellent technical assistance. AWJ is supported by the UCLA Pathology Translational Research Fund. MM is supported by NIH MARC T34 GM008563.
Conflict of interest
The authors declare that they have no conflict of interest.
- 5.Murray IR et al. (2013) Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci CMLS. doi: 10.1007/s00018-013-1462-6
- 11.James AW et al. (2012) Use of human perivascular stem cells for bone regeneration. J Vis Exp JoVE e2952. doi: 10.3791/2952
- 15.Fletcher C, Unni K, Mertens F (2002) World Health Organization classification of tumours. IARC Press, LyonGoogle Scholar
- 16.Weiss S, Goldblum J (2008) Enzinger and Weiss’s soft tissue tumors. Mosby Elsevier, PhiladelphiaGoogle Scholar
- 18.Gombos Z, Zhang PJ (2009) Glomus tumor. Arch Pathol Lab Med 132:1448–1452Google Scholar
- 21.Porter PL, Bigler SA, McNutt M, Gown AM (1991) The immunophenotype of hemangiopericytomas and glomus tumors, with special reference to muscle protein expression: an immunohistochemical study and review of the literature. Mod Pathol Off J U S Can Acad Pathol Inc 4:46–52Google Scholar
- 22.Boyde A (1980) Diagnostic electron microscopy of tumours. F.N. Ghadially, Butterworth Co (Publishers) Ltd., LondonGoogle Scholar
- 23.Erlandson R (1994) Diagnostic transmission electron microscopy of tumors. Raven Press, New YorkGoogle Scholar
- 40.Barnhill RL, Lugassy C (2004) Angiotropic malignant melanoma and extravascular migratory metastasis: description of 36 cases with emphasis on a new mechanism of tumour spread. Pathology (Phila) 36:485–490Google Scholar